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Background The use of oral contraceptive pills are increasingly becoming popular among women in both urban 
and rural Nigerian settings, its perceived association with gynaecologic infections not withstanding. 
Aim: To ascertain the rate of urogenital candidiasis among women on oral contraceptive pills (OCP) in Gboko 
town.  
Methods: All the willing women on OCP attending family planning clinic and Comprehensive health centre in 
Gboko were consecutively recruited in the month of September, 2009. Questionnaires were used to obtain 
relevant data such as age, marital status, occupation and urogenital symptoms. Urine, High vaginal swab and 
Endocervical swab specimens were subsequently collected, transported and processed for isolation of 
microorganisms using standard laboratory procedures. 
Results The rate of urogenital candidiasis among the 153 women on OCP was significantly higher 36.5% 
compared to the control 20.3% (P< 0.05) in as much as their general knowledge about the disease was poor; 
similarly, genitourinary symptoms were recorded in 22.2% of the women on OCP as compared to the 5.2% in the 
control group (P< 0.001) and was significantly higher among the singles, separated, widowed and separated (64.4-
64.7%) compared to the married 27% (P< 0.05). 79.4% of the symptomatic infections were caused by Candida spp.  
Conclusion Women should be properly counselled and health educated on the need for prompt and adequate 
treatment of vulvovaginal candidiasis while facilities for appropriate treatment and proper laboratory diagnosis 
provided.   
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INTRODUCTION 
Vulvovaginal candidiasis is not a rare 
gynaecological finding among women from 
both temperate and tropical parts of the world 
(1-3). These infections, when asymptomatic 
may persist for long periods of time with out 
obvious sequelae. The disease however poses 
serious health risks to pregnant women and the 
unborn children. In Poland, treatment of 
recurrent candidiasis in pregnant women was 
accompanied by increased episodes of bacterial 
vaginosis with risks of preterm labour (4); in 
Minnesota USA, development of candida 
chorioamnionitis with preterm labour and 
subsequent development of congenital 
candidiasis of the new born was reported (5); 
and in Canada, pregnant women recorded 
significantly higher rates of candidal urinary 
tract infections with obvious risks to the 
mother and the unborn child (6). 
 
Since the advent of human immunodeficiency 
virus (HIV) infection in 1982 to date, the 
clinical relevance of vaginal candidiasis has 
proportionately deepened along with the 
course of other sexually transmitted disease 
(STDs) (7,8). The disease was found to 
contribute significantly to the spread of HIV 
infections at the onset of this disease’s global 
epidemic and proper treatment of the disease 
along with other STDs was strongly 
recommended for effective of control of HIV 
AIDS in communities (9,10).  
 
At present HIV AIDS is still a major problem in 
Nigeria as well as other parts of sub-Saharan 
Africa, a region believed to harbour at least 
70% of the global burden of the disease (11,12). 
Proper and efficient control of the disease still 
appears to be a major challenge among African 
communities especially in the treatment and 




study was set up to assess the level of 
vulvovaginal candidiasis among pregnant 
women in an urban community and their 
attitudes towards its control. The findings 
would be useful as one of the tools to assess 
maternal and child health care services in the 
community towards attainment of the 
millennium development goals (MDG) (13,14).  
MATERIALS AND METHODS 
Setting  
The study was carried out in September 2009 in 
Gboko town, arguably the second largest town 
in Benues state situated about 82 kilometres 
north-east of Makurdi the state Capital. Based 
on 2006 population census, the town has an 
estimated population of 300,000 people; over 
95% of the population is made up of Tiv people 
who are predominantly farmers by occupation 
and Christians by religion. Two major health 
centres- General hospital (GH) and 
Government comprehensive health centre 
(GCH) centre are located in the town which 




Pregnant women attending ante-natal clinic at 
GH and GCH centre were recruited into the 
study. Pre-tested questionnaires were 
administered either self or interviewer to the 
respondents to obtain relevant information. 
These include age, marital status, occupation, 
and educational level, knowledge about 
candidiasis and presence or absence of genital 
symptoms. 
All the women who volunteered to enrol in the 
study were consecutively recruited into the 
study throughout the study period. Pre-
enrolment briefing about the study was carried 
out for each participant then informed written 
or oral consent obtained from them. A control 
group, age matched was drawn from 
apparently healthy women attending the GCH 
centre for other reasons other than family 
planning and who were not on oral 
contraceptive pills.  
 
Sample collection and Processing  
High vaginal swab (HVS), Endocervical swab 
(ECS) and urine specimens were collected from 
both the test and control subjects using 
standard laboratory procedures and 
transported to the GH Gboko laboratory within 
one hour of collection. Wet preparations were 
carried out on the specimens and examined 
microscopically using X40 objective lens (15). 
The specimens were inoculated on Sabouraud’s 
dextrose agar, Chocolate, Blood agar, 
Macconkey agar and Cystein lactose electrolyte 
deficient (CLED) agar and incubated overnight 
at 36.5OC. Candida species were identified based 
on cultural characteristics, gram stain and cell 
morphology, and biochemical properties using 
germ tube test, chlamydospore formation test 
and carbohydrate fermentation (15,16). Bacteria 
were identified using relevant and appropriate 
biochemical tests such as catalase test, oxidase 
test, coagulase test, citrate utilization, urea 
hydrolysis, motility, sugar fermentations and 
sulphide production (15,16). 
Analysis of Results Results obtained were 
analysed using Epi Info 6 statistical software, P 
values ≤ 0.05 were considered significant.  
 
RESULTS  
One Hundred and fifty three pregnant women 
were interviewed and urogenital samples 
subsequently collected and processed during 
the study period, and a corresponding 153 
samples were collected from age matched 
females who were not pregnant. The rate of 
urogenital colonization by Candida species 
among pregnant women was 47.7% (73/153) 
while 20.3% (31/153) was recorded among the 
control (95% CI, OR=1.28-4.53, RR=1.95-3.09, 
P< 0.01). Over all, the rate of genitourinary 
symptoms were recorded in 28.8% (44/153) 
and 5.2% (8/153) of the test and control 
subjects respectively (95% CI, OR=2.03-17.84, 
RR= 1.89-11.77, P< 0.001). Candida spp.  were  
recovered from 84.1% (37/44) of pregnant 
women with urogenital symptoms; other 
microbial isolates recovered were Trichomonas 
vaginalis 6.8% (3/44), Proteus mirabilis 4.5% 
(2/44), and both Enterococcus spp. and Others 
2.3% (1/34) each. Also 87.5%  (7/8) of the 
isolates from the control group with urogenital 
symptoms were Candida spp. while the only 
other single isolate recovered was Trichomonas 
vaginalis (12.5%) (P> 0.05). 
 
TABLE 1: AGE DISTRIBUTION PATTERN AND  
RATE OF VULVOVAGINAL CANDIDIASIS 
AMONG PREGNANT WOMEN IN GBOKO, 










≤ 20 5 (3.3) 12 (7.8) 17 (11.1) 
21-25 18 (11.8) 15 (9.8) 33 (21.6) 
26-30 9 (5.9) 19 (12.4) 28 (18.3) 
31-35 24 (15.6) 15 (9.8) 39 (25.5) 
36-40 11 (7.2) 10 (6.5) 21 (13.7) 
≥41 6 (3.9) 9 (5.9) 15 (9.8) 
Total 73 (47.7) 80 (52.3) 153 (100) 
X2 (Yates corrected)= 0.41, OR=  




Those who did not know Candidiasis as a 
disease were 94.1% (144/153) and 95.4% 
(7/153) could not list at least one urogenital 
symptom unique to candidiasis; 83.6% 
(134/153) of the respondents felt there was no 
compelling need for treatment while 86.3% 
(132/153) did not consider the disease of any 
serious clinical significance.  Also, 94.1% 
(144/153) could not mention at least one valid 
health risk associated with candidiasis. 
 
A review of the age distribution pattern of 
vulvovaginal candidiasis among the 
respondents showed that those aged 31-35, 21-
25 and 36-40 years had 15.6% (24), 11.8% (18) 
and 7.2% (11) infections respectively with no 
significant age difference (P> 0.05). (Table 1) 
Analysis of clinical features associated with 
vulvovaginal candidiasis among the 
respondents with candidal colonization 
showed that 39.7% (29) had no symptoms, 
15.1% (11), 17.8% (13), 9.6% (7) and 2.7% (2) 
had itching, discharge, rashes and waist pain 
respectively as the only complaint while others 
presented these feature in varying 
combinations. (Table 2) 
 
TABLE 2: CLINICAL FEATURES ASSOCIATED 
WITH VULVOVAGINAL CANDIDIASIS 
AMONG PREGNANT WOMEN IN GBOKO, 





Nil 29 (39.7) 













Waist Pain 2 (2.7) 




Total 73 (100) 
 
Based on occupational distribution of the 
respondents, 51.2% (21), 61.4% (43/70) and 
35.7% (5/14) of the applicants, farmers and 
petty traders were respectively infected while 
14.3% (1/7) civil servants and 16.7% (3/18) 
were respectively infected (RR=3.0, CI=3.3-4.2). 
(Figure 1) 
Among the Candida species recovered, C. 
albicans 64.4% (47), C. glabrata 15.1% (11), C. 
stellatoidea and C. tropicalis 6.8% each (5) were 
the four most common species. All the Candida 
species were recovered from genital specimens 
and none from urine specimens. Urinary tract 
infection was detected in 1.3% (2) of the 
subjects with Proteus mirabilis and Enterococcus 
species respectively being responsible. (Table 3). 
 
FIGURE 1 OCCUPATIONAL DISTRIBUTION 
AND RATE OF VULVOVAGINAL CANDIDIASIS  
AMONG PREGNANT WOMEN IN GBOKO,  
NORTH CENTRAL NIGERIA (N=153) 
 
A             B                C              D                    E 
 
       OCCUPATIONAL DISTRIBUTION 
A= applicants   B= Farming    C= Petty trading 
        N=41                   n=70                n=14 
D= Civil servant           E=Artisan 
         N=7                                 n=18 
NB: Full time housewives were also grouped  
as applicants; *= P < 0.05 
 
Analysis of the modes of transmission of 
candidiasis among the respondents showed 
that 58.2% (89), 36.6% (56) and 23.5% (36) 
attributed acquisition from toilet, dirty water 
and insects respectively; 12.4% (19) and 8.5% 
(13) attributed it to cold and sexual means 
respectively; 17.6% (27) had no idea while 2.0% 
(3) attributed the infections to other factors 
such as dirty hands and seats. (Table 4) 
A review of the modes of treatment showed 
that 76.5% (117), 12.4% (19) and 11.1% (17) 
respectively usually sought no treatment, visit 
hospital or clinic, and take traditional herbs. 
Those who would mention correctly at least 
one antifungal drug for its treatment were 17 
(11.1%). (Figure 2)  
 
TABLE 3 SPECIES OF CANDIDA RECOVERED 
FROM UROGENITAL SPECIMENS OF 
PREGNANT WOMEN IN GBOKO, NORTH 
CENTRAL NIGERIA (N=73). 
Candida Species Number (%) 
















Unspecified 1 (1.4) 
Total 73 (100) 
 
























TABLE 4 MODES OF TRANSMISSION OF  
CANDIDA SPECIES ADVANCED BY PREGNANT  
WOMEN IN GBOKO, NORTH CENTRAL 





Toilet 89 (58.2) 
Dirty Water 56 (36.6) 
Insects 36 (23.5) 
Cold 19 (12.4) 
Sexual Means 13 (8.5) 
Others 3 (2.0) 
No Idea 27 (17.6) 
 
NB: Respondents were allowed to  
identify more than one option. 
 
Based on educational levels, 40.0% (61), 30.7% 
(47), 20.5% (31) and 9.0% (14)of the respondents 
had nil, primary, secondary and tertiary 
education respectively with no significant 
difference in the rate of infection (P> 0.05). 
Also, 147 (96.0%), 3 (2.0%) and 3 (2.0%) of the 
respondents were married, separated or 
widowed of divorced, and singles respectively 
with no significant marital difference (P> 0.05).   
 
 
FIGURE 2 MODES OF TREATMENT OF  
VULVOVAGINAL CANDIDIASIS AMONG  
PREGNANT WOMEN IN GBOKO, NORTH 










The incidence of asymptomatic vulvovaginal 
candidiasis among pregnant women in Gboko 
of 47.7% was significantly higher than that of 
the control (20.3%) (P< 0.001); similarly the rate 
of symptomatic candidiasis among the 
pregnant women significantly hiher (28.8% vs 
5.2%) (P< 0.001). The general knowledge about 
the disease among the women was poor 
especially as concerning modes of 
transmission, treatment attitudes, and most 
especially health implications. The level of care 
by the respondents was similarly low as none 
of them with candidal symptoms came to the 
clinic primarily for it. Only 12.4% would visit 
clinic for its treatment however, none of the 
women found with symptomatic candidiasis 
visited clinic with the aim to seek medical 
attention for it. The infections were found to be 
strongly associated with farmers, applicants 
and petty traders (CI=3.3-4.2). 
 
The findings from the present study partly 
agrees with findings from similar studies in: 
Italy where candidiasis was detected in 53.3% 
of the women studied and was the single most 
common infection (17); Israel where Candida 
species constituted the highest number of 
microorganisms recovered and were detected 
in 35.5% of the women (18); Poland where 
Candida was recovered from 20.7% of the 
genital specimens of women in labour and was 
the commonest organism (19); and in Bulgaria 
where a much higher figure of recurrent 
vaginal candidiasis of 85.72% was documented 
among pregnant women (20). The correlation 
of the disease with certain groups of people 
such as farmers, petty traders and applicants is 
most probably a reflection of the general trend 
of the disease in the community which strongly 
points towards socioeconomic factors11,12,19. 
 
Candida albicans was the single most common 
specie recovered from the genital specimens 
followed by Candida glabrata. This pattern of 
Candida species recovered corroborates fairly 
with findings from Tanzania (21), Sweden22, 
Italy23 and Nigeria24 where Candida albicans was 
the single most common specie recovered from 
the genital specimens processed. The relatively 
higher rate of C. glabrata recovered in 
Germany25 from a similar study could be 
attributed to, most probably regional or 
geographic specie variations, although, the 
influence of genetic factors may need to be 
explored. 
 
The species of Candida recovered from the 
present study are slightly different from that of 
Nikolov, et al in Bulgaria where Candida 
parapsilosis was isolated20, and in Spain where 
Candida krusei was recovered (26). Besides 
confirming the world wide distribution of 
infectious Candida species, the lack of adequate 
laboratory facilities in the present study could 
have influenced the scope of speciation of the 
Candida isolates. Paucity of laboratory facilities 
and competent laboratory personnel was noted 
as a general problem by the research team in 
most of the health centres in the community. 
 
RECOMMENDATIONS 
In view of the low level of understanding and 








Traditional Herbs (17) 





among pregnant women in Gboko, health 
education should be instituted at the ante-natal 
clinics as well as other clinics where pregnant 
women seek similar services. This would raise 
their level of awareness and correct their 
perception towards the need for its prompt 
treatment as well as other STDs These health 
talks should be extended by appointed health 
educators or voluntary health educators to 
other social and informal gatherings of women 
in the community.   
 
Due to the high prevalence of HIV AIDS 
presently in the country as a whole (11,1)2, safe 
and protective sex should be strongly 
advocated with proper sex education to the 
people. This campaign should involve both 
pregnant and non pregnant women so as to 
reduce the risk posed by symptomatic Candida 
infections towards the transmission of other 
STDs including HIV. 
Towards improving maternal and child health 
in the community and with the present high 
level of candidiasis among pregnant women, 
routine screening for symptomatic 
vulvovaginal candidiasis should be instituted 
at hospitals and clinics in the locality. This 
would protect both the mother and child from 
both the primary and secondary effects of the 
disease (27-29). 
Government in collaboration with her 
regulatory authorities should review 
guidelines for setting up hospitals and clinics 
in the country. This should include, among 
others, a minimum basic requirement for 
effective laboratory diagnosis of STDs as well 
as other infectious diseases since these diseases 




The rate of symptomatic vulvovaginal 
candidiasis among pregnant women in Gboko 
is high with a corresponding low level of 
awareness and care about the disease. Health 
education should be instituted at ante-natal 
clinics so as to raise the knowledge and level of 
awareness of the people towards seeking 
prompt and appropriate treatment.  
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